drugset / Trial / NCT00056277

Bipolar Disorder Study for Men and Women

NCT00056277

Phase 3 Completed 150 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

A Placebo Controlled Study Evaluating Efficacy and Safety of Medication in Patients with Bipolar Disorder

Timeline

Start
2003-02-27
Primary completion
2005-08-01
Completion
2005-12-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule

Indications